Tag: Neurology and Neuroscience
-
Krainc to receive $9 Million, 8-year NIH Grant
Dimitri Krainc, MD, PhD, has received a Research Program Award grant from the National Institute of Neurological Disorders and Stroke (NINDS).
-
Interaction of Mitochondria and Lysosomes Key in Parkinson’s Disease
Prolonged contact between the mitochondria and the lysosome causes aberrant distribution of mitochondria, contributing to neuronal dysfunction in Parkinson’s disease.
-
Mapping Neural Connections in Parkinson’s Disease
Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
-
PPA Conference Builds Connections in the Aphasia Field
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
-
Inflammation Protection May Be Critical to Treating MS
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis, according to a recent study.
-
Next-Gen Sequencing
Northwestern’s investment in next-generation sequencing is leading to unprecedented avenues of discovery.
-
Conformational Switch Implicated in Neurodegenerative Diseases
Northwestern Medicine scientists have discovered a conformational “switch” that determines the function of the SNARE protein Ykt6, with implications for synucleinopathies, according to a recent study.
-
Lurie Children’s Receives $4 Million to Study Lennox-Gastaut Syndrome
Northwestern and Lurie Children’s Hospital investigators have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study Lennox-Gastaut Syndrome.
-
New Spherical Nucleic Acid ‘Drug’ Kills Tumor Cells in Humans With Glioblastoma
An experimental spherical nucleic acid drug developed by Northwestern scientists was able to penetrate the blood-brain barrier and trigger the death of glioblastoma cells.
-
New Genetic Cause of Dystonia Revealed
Northwestern Medicine scientists discovered mutations in a scaffolding protein contributes to dystonia, an incurable movement disorder.
